Trajectories of Oral PrEP Adherence Among Young Kenyan Women: Implications for Promoting Effective PrEP Use

被引:0
作者
Nicholas Musinguzi
Maria Pyra
Elizabeth A. Bukusi
Nelly R. Mugo
Jared M. Baeten
Jessica E. Haberer
机构
[1] Mbarara University of Science and Technology,Global Health Collaborative
[2] University of Chicago,Department of Medicine
[3] University of Washington,Department of Obstetrics and Gynecology
[4] Kenya Medical Research Institute (KEMRI),Center for Clinical Research (CCR)
[5] University of Washington,Department of Global Health
[6] University of Washington,Department of Epidemiology
[7] University of Washington,Department of Medicine
[8] Massachusetts General Hospital and Harvard Medical School,Department of Medicine
[9] Harvard Medical School,undefined
来源
AIDS and Behavior | 2023年 / 27卷
关键词
PrEP; Adherence; Trajectories; Kenya;
D O I
暂无
中图分类号
学科分类号
摘要
Using data from a 2-year study of young women at high HIV risk in Thika and Kisumu, Kenya, we identified group-based trajectories of PrEP adherence based on electronic pillcap-monitoring and assessed potentially associated demographic and socio-behavioral factors. Among 348 women, we selected a three-trajectory adherence model: low and declining (N = 211, 61%), moderate but declining (N = 119, 34%) and steady high adherers (N = 18, 5%). We also identified a two-trajectory HIV risk model based on self-perceived risk in the past week: high and increasing (N = 28, 8%) and steady low (N = 320, 92%) risk. The Kisumu site was associated with the moderate but declining and steady high adherence trajectories, while increasing VOICE risk score was associated with the low and declining adherence trajectory. We found no association between the adherence and risk trajectories. Our findings suggest adherence support may need tailoring by setting. Early, sustained support may also help those at highest risk of non-adherence.
引用
收藏
页码:171 / 181
页数:10
相关论文
共 195 条
  • [1] Baeten JM(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 399-410
  • [2] Donnell D(2018)Weighing the evidence of efficacy of oral PrEP for HIV prevention in women in Southern Africa AIDS Res Hum Retroviruses 34 645-656
  • [3] Ndase P(2016)A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine J Infect Dis 214 55-64
  • [4] Mugo NR(2011)Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women Lancet 378 279-281
  • [5] Campbell JD(2015)Tenofovir-based preexposure prophylaxis for HIV infection among African women N Engl J Med 372 509-518
  • [6] Wangisi J(2012)Preexposure prophylaxis for HIV infection among African women N Engl J Med 367 411-422
  • [7] Janes H(2021)PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: results from HPTN 082, a randomized controlled trial PLoS Med 18 1551-1559
  • [8] Corey L(2018)Trajectories and predictors of longitudinal preexposure prophylaxis adherence among men who have sex with men J Infect Dis 218 3718-3725
  • [9] Ramjee G(2018)Patterns of oral PrEP adherence and HIV risk among Eastern African women in HIV serodiscordant partnerships AIDS Behav 22 495-510
  • [10] Carpp LN(2018)A group-based trajectory model for changes in pre-exposure prophylaxis and condom use among men who have sex with men participating in the ANRS IPERGAY trial AIDS Patient Care STDS 32 2046-2053